BNOS 2018 presentations

 

* BNOS 2018 Highlights
* Welcome to BNOS 2018
* Keynote speaker presentations
* Abstract author presentations & Young Investigator Award

Videos by Geoff Cross


 

BNOS 2018 Highlights

 

 


 

Welcome to BNOS 2018

  • Chair of local organising committee Mr Paul Grundy, and President of BNOS, Prof Silvia Marino



 

Keynote speaker presentations

BNOS 2018 – Day 1:  Wednesday 4th July 2018


 

  • Keynote speaker: Imaging for cerebral metastases – Current and future approaches – Dr Gerry Thompson


 

  • Keynote speaker: Surgery for cerebral metastases – Current and future approaches – Dr Viviane Tabar


 

  • Keynote speaker: Radiotherapy for cerebral metastases – Current and future approaches – Dr Liam Welsh


 

  • Keynote speaker: Immunotherapy for cerebral metastases – Current and future approaches – Prof Christian Ottensmeier


 

  • Keynote speaker: Pathology for cerebral metastases – Current and future approaches – Dr Mark Walker


 

  • Keynote speaker: 2018 NICE guidelines for the management of primary and secondary brain tumours impact on current practice, on-going controversies and challenges – Prof Garth Cruikshank


Keynote speaker presentations

BNOS 2018 – Day 2:  Thursday 5th July 2018


 

  • Keynote speaker: A preclinical model of mutant histone-driven paediatric glioma – Dr Manav Pathania


 

  • Keynote speaker: Shared decision making in neuro-oncology – What is it and why does it matter? – Prof Alf Collins


Sponsored by The Brain Tumour Charity:  Stephen Baker Memorial Lecture

  • Keynote speaker: Communication with patients and relatives – How to do it well. A wife’s perspective – Ms Holly Matthews


Keynote speaker presentations

BNOS 2018 – Day 3:  Friday 6th July 2018


 

  • Keynote speaker: Integrating regenerative stem cell science into cancer research – Dr Viviane Tabar


 

  • Keynote speaker: Proton beam therapy for brain tumours – Current and future approaches – Prof Damien Weber


 

  • Keynote speaker: Management of spinal cord tumours – Current and future approaches – Mr Ali Nader-Sepahi



 

Abstract author presentations

BNOS 2018 – Day 1:  Wednesday 4th July 2018


 

  • Pathology for cerebral metastases – Current and future approaches – Dr Mark Walker


 

  • BRIAN the charity’s Brain tumouR Information and Analysis Network – Prof Keyoumars Ashkan


 

  • Genomic profiling of primary and matched recurrent glioblastoma tumours reveals that the mutational landscape includes clinically actionable variation – Dr Kathreena Kurian


 

  • Three-dimensional multicolour lineage tracing of intrinsic brain tumour models – Mr James Innes


 

  • SERPINE1 identified as potential therapeutic target through RNA-Seq of clinically relevant invasive glioblastoma cells isolated from patients by 5-ALA based methodology – Mr Jonathan Rowlinson


 

  • Exploring alignment-free sequence comparison methods to elucidate patterns of evolution and heterogeneity in longitudinal glioma patient cohorts – Dr Darragh McArt


 

Abstract author presentations

BNOS 2018 – Day 2:  Thursday 5th July 2018


 

  • BREAKFAST SEMINAR: CANCER RESEARCH UK New horizons in brain tumour research – Ms Safia Danovi


 

  • Large volume re-irradiation is a viable option in patients with recurrent refractory glioblastoma – Prof Michael Back


 

  • Reoperation in glioblastoma – Is it worth it? – Mr Benjamin Hall


 

  • The survival of glioblastoma multiforme patients after burr hole biopsy based their post biopsy treatment with or without chemotherapy and/or radiotherapy – Mr Georgios Zilidis


 

  • Shared decision making, the bridge between paternalism and autonomy – Mr Julian Cahill


 

  • The development of an interdisciplinary assessment clinic to address the health related quality of life (HRQOL) issues of patients with a meningioma – Prof Philip Kane


 

  • Neurocognitive profile of patients with hemispheric low grade astrocytoma and oligodendroglioma – Mr Alex Leggate


 

  • How should we support patients with primary brain tumours who elect to take Cannabinoids? – Ms Jessica La


 

  • Patient satisfaction with day-case brain biopsy – Ms Joy Roach


 

  • First UK experience with navigated transcranial magnetic stimulation in pre-surgical mapping – Dr Josephine Jung


 

  • Seizure prophylaxis in glioma – UK neurosurgical survey and clinical trial – Prognostic indices for brain metastases – Which best reflects a UK cohort, and what is the prognosis of our metastasis patients? – Mr Michael Jenkinson


 

  • Low grade glioma clinic – Establishing an innovative service based on a multidisciplinary approach – Mrs Charlotte Robinson


 

  • Day-case brain tumour biopsy – Our experience over eight years – Functionally guided supramaximal resection of IDH-wildtype glioblastomas and the effect on progression free survival – F Saeed


 

  • Prognostic indices for brain metastases – Ms Kathrin Whitehouse


 

  • A phase I expansion study of pegargiminase, cisplatin and pemetrexed in argininosuccinate synthetase 1-negative recurrent high grade gliomas (HGGs) – Dr Peter Hall


 

  • Stereotactic radiosurgery for patients with melanoma and multiple brain metastases – Experience during the era of immunotherapy and targeted agents – Dr Paul Sanghera


 

Abstract author presentations & Young Investigator Award

BNOS 2018 – Day 3:  Friday 6th July 2018


 

  • Young Investigator of the Year: Improving our understanding and management of brain metastases – Dr Rasheed Zakaria


 

  • Top 4 scoring papers

– Analysis of cranial adult pilocytic astrocytomas in a 10 year period – Alex Leggate, Manchester
– Neurosurgical management of brain metastases: outcomes and trends from a major neurosurgical centre – Charles Hand, Nottingham
– Radiomic evaluation of treatment response in patients with glioblastoma.  A Pilot study – Markand Patel, Birmingham
– Epigenetic adaptation to therapy in glioblastoma: popping the hood on therapeutic resistance – Seamus Caragher, Northwestern University, Washington DC, USA

 





 

  • Bridging the gap – Benefits of neurosurgical tissue for pre-clinical research – Mr Aminul Ahmed


 

  • Management and outcomes of incidental meningiomas – Is routine follow-up required? – Mr Abdurrahman Islim


 

  • Gliomas genetic markers and preferential supratentorial brain locations – Mr Isaac Phang


 

  • A pilot study of the acceptance and tolerability of tumour treating fields in adult glioblastoma patients – Mr Andrew Brodbelt


 

  • NIHR and brain tumours – Mr Michael Jenkinson


 

  • Using qualitative research methods to optimise recruitment – The ROAM (radiation versus observation following surgical resection of atypical meningioma) Information Study – Mr Michael Jenkinson


 

  • The story behind the data – Developing the conversation about brain cancer data beyond traditional indicators – Dr Helen Bulbeck


 

  • Membrain project – Provisional results of UK national, prospective audit on the management evaluation of metastases in the brain – Dr Josephine Jung


 

  • Medulloblastoma incidence and survival – A population based study – Dr Martin McCabe